MILWAUKEE, June 29, 2023 /PRNewswire/ -- Ademi LLP is investigating Sigilon (Nasdaq:SGTX) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli Lilly.
Read more at prnewswire.comShareholder Alert: Ademi LLP investigates whether Sigilon Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here